MedTrace Logo

Preventing Fetal Body and Brain Size Reduction in Low-income Smoking Mothers: A Randomized Clinical Trial

NCT01248260 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 495

Last updated 2019-02-15

No results posted yet for this study

Summary

The purpose of this study is to find out if folic acid prevents of the reduction of fetal body and brain size in infants whose mothers smoke.

Conditions

  • Fetal Body Size
  • Fetal Brain Size

Interventions

DIETARY_SUPPLEMENT

Folic Acid

4mg of higher strength folic acid once a day until delivery

Sponsors & Collaborators

  • Hamisu Salihu

    lead OTHER

Principal Investigators

  • Hamisu M Salihu, MD, PhD · University of South Florida

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01248260 on ClinicalTrials.gov